By Monee Hanna and Nicholas Janizeh April 2, 2018, 1:30 PM EDT
Law360 (April 2, 2018, 1:30 PM EDT) -- “[O]ur careful review of the federal regulatory scheme ... persuades us that a brand-name drug manufacturer has the duty ... to warn of the risks about which it knew or reasonably...Innovator Liability: A Pandora’s Box For Pharma Cos.?
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login